Legacy Capital Partners Inc. boosted its position in UnitedHealth Group Inc. (NYSE:UNH) by 17.0% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 6,180 shares of the healthcare conglomerate’s stock after buying an additional 900 shares during the period. Legacy Capital Partners Inc.’s holdings in UnitedHealth Group were worth $873,000 as of its most recent filing with the SEC.
Other large investors have also recently modified their holdings of the company. MCF Advisors LLC boosted its stake in shares of UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock worth $123,000 after buying an additional 726 shares during the last quarter. Parkside Financial Bank & Trust boosted its stake in shares of UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 238 shares during the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in shares of UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $153,000 after buying an additional 518 shares during the last quarter. Feltz Wealth PLAN Inc. purchased a new stake in shares of UnitedHealth Group during the second quarter worth approximately $143,000. Finally, Evanson Asset Management LLC purchased a new stake in shares of UnitedHealth Group during the second quarter worth approximately $201,000. 85.78% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Inc. (NYSE:UNH) opened at 140.51 on Friday. UnitedHealth Group Inc. has a 12 month low of $107.51 and a 12 month high of $144.48. The firm has a market capitalization of $133.82 billion, a P/E ratio of 21.99 and a beta of 0.57. The stock’s 50 day moving average price is $138.79 and its 200-day moving average price is $135.32.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The business had revenue of $46.50 billion for the quarter, compared to the consensus estimate of $45.05 billion. On average, analysts forecast that UnitedHealth Group Inc. will post $7.92 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were given a $0.625 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.78%. UnitedHealth Group’s dividend payout ratio is currently 39.12%.
A number of brokerages have recently commented on UNH. Credit Suisse Group AG reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Leerink Swann reaffirmed an “outperform” rating and set a $165.00 price objective (up previously from $155.00) on shares of UnitedHealth Group in a research note on Wednesday, July 20th. FBR & Co reiterated an “outperform” rating and set a $155.00 target price (up previously from $145.00) on shares of UnitedHealth Group in a research report on Wednesday, July 20th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 target price on the stock in a research report on Friday, July 22nd. Finally, Oppenheimer Holdings Inc. reiterated an “outperform” rating and set a $161.00 target price (up previously from $145.00) on shares of UnitedHealth Group in a research report on Friday, July 22nd. One analyst has rated the stock with a hold rating, twenty-four have issued a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and an average target price of $154.96.
In related news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares in the company, valued at $271,100,350.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.65% of the stock is owned by insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.